Conditions: Overactive Bladder
Keywords: OAB, anticholineric, oxybutynin, urge urinary incontinence
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 789
Healthy volunteers: no

Brief summary:
A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.

Detailed description:

Arms:
arm 1: Oxybutynin topical gel arm 2: placebo topical gel

Interventions: intervention 1: Oxybutynin topical gel intervention 2: Placebo topical gel
Intervention descriptions: intervention 1: 1 application daily to skin for 12 weeks intervention 2: 1 application daily to skin for 12 weeks

Protocol document: